New Zealand, legal highs and sensible supply-side policies

Existing policy in the UK is rooted in the false assumption that if you make something illegal, people will stop doing it.

The UK government could learn a lot from New Zealand about how to sensibly control the proliferating supply of so-called “legal highs”, according to the All-Party Parliamentary Group for Drug Policy Reform

While governments in Europe and the United States frantically ban substances to keep up with new synthetic drugs, lawmakers in New Zealand are using reason and a sensible legislative process to “to protect vulnerable consumers, particularly young people.”

Yet far from being another ham-fisted crackdown on drugs, the New Zealand proposal represents the first steps to a regulated market, which would require any new substances to go through a lengthy testing process before they could be approved for legal sale.

Potential manufacturers of new psychoactive substances will have to submit to roughly $180,000 NZD (£95,000 GBP) in application fees plus an additional NZ$1m to NZ$2m (around £526,000 to £1.05m) in costs to test each product they want to sell.

And there are strict penalties for attempts to bypass the law, which could go into effect later this year, including up to eight years in prison.

This is a monumental development for a number of reasons.

First, it has always been difficult to separate the impact of drugs from the impact of bad policies (as the peers group rightfully acknowledged). There is no doubt that so-called “legal highs” (sold as plant food, collector’s items or bath salts) can be very dangerous. But every time they are banned, new – even more hazardous – substitutes hit the market to take their place.

This creates a “Sorcerer’s Apprentice” situation where we find ourselves wishing we were only facing the original adversary. Consider that many synthetic substances in Europe are substitutes for cannabis. In 2011, the European Union officially notified 49 new psychoactive substances through its early warning system, 23 of which were synthetic cannabinoids.

While there are risks to using cannabis that should certainly be addressed, no-one is ever known to have suffered a fatal overdose on it and its health impacts are considerably better understood than its synthetic counterparts.

“Evidence presented here indicates that, paradoxically, the banning of one drug can make the situation worse by stimulating the production of yet more new, unknown and potentially dangerous substances,” the All-Party group writes.

The New Zealand policy aims to halt the legislative incentive to develop more new drugs.

Furthermore, one very serious danger of current policies on synthetic substances is that their main purpose for being is to evade accountability. As it stands, legal highs – though often using banned components – exist in a grey area. As various pieces of legislation scramble to control them, various substances often remain unregulated, unknown and out of control. No one knows their impacts and the only way to find out is by hard, sometimes deadly, experience.

And once the system takes control – via criminal sanctions – the process begins again with newer more enigmatic substances emerging.

“Each new substance may be more harmful than the substance it replaces,” the report adds. “But more than anything, young people are taking substances whose content and strength are unknown to them. The risks of harm/overdose must be greater than for well established substances.”

Which leads us to the most important factor in this new policy -- it may actually tell us something about prohibition in general.

In 2008, the United Nations Office on Drugs and Crime discussed unintended consequences of the current control system. One was referred to as “substance displacement” – which is to say, “If the use of one drug was controlled, by reducing either supply or demand, suppliers and users moved on to another drug with similar psychoactive effects, but less stringent controls … The increasing popularity of synthetic drugs can be better understood also in this light.”

This comes very close to acknowledging that potentially harmful legal highs are a byproduct of prohibition.

Existing drug policies are generally rooted in the false assumption that if you make something illegal, people won’t use it and hence they will be protected from its harms. In the end, the exact opposite tends to be true because once something is illegal, the standard policy levers of government are out of reach.

As the All-Party group writes, “A useful feature of New Zealand’s planned policy is to assess both the harms arising from a particular substance and the harms arising from controlling it.”

Might we the UK also be better served by begin regulatory processes to understand the drugs that people are taking and developing policies that address their relative risks?

That is precisely what New Zealand has started doing. It’s worth a closer look.

Kasia Malinowska-Sempruch is the director of Open Society Foundations Global Drug Policy Program

Photograph: Getty Images

Kasia Malinowska-Sempruch is the director of Open Society Foundations Global Drug Policy Program.

Ukip's Nigel Farage and Paul Nuttall. Photo: Getty
Show Hide image

Is the general election 2017 the end of Ukip?

Ukip led the way to Brexit, but now the party is on less than 10 per cent in the polls. 

Ukip could be finished. Ukip has only ever had two MPs, but it held an outside influence on politics: without it, we’d probably never have had the EU referendum. But Brexit has turned Ukip into a single-issue party without an issue. Ukip’s sole remaining MP, Douglas Carswell, left the party in March 2017, and told Sky News’ Adam Boulton that there was “no point” to the party anymore. 

Not everyone in Ukip has given up, though: Nigel Farage told Peston on Sunday that Ukip “will survive”, and current leader Paul Nuttall will be contesting a seat this year. But Ukip is standing in fewer constituencies than last time thanks to a shortage of both money and people. Who benefits if Ukip is finished? It’s likely to be the Tories. 

Is Ukip finished? 

What are Ukip's poll ratings?

Ukip’s poll ratings peaked in June 2016 at 16 per cent. Since the leave campaign’s success, that has steadily declined so that Ukip is going into the 2017 general election on 4 per cent, according to the latest polls. If the polls can be trusted, that’s a serious collapse.

Can Ukip get anymore MPs?

In the 2015 general election Ukip contested nearly every seat and got 13 per cent of the vote, making it the third biggest party (although is only returned one MP). Now Ukip is reportedly struggling to find candidates and could stand in as few as 100 seats. Ukip leader Paul Nuttall will stand in Boston and Skegness, but both ex-leader Nigel Farage and donor Arron Banks have ruled themselves out of running this time.

How many members does Ukip have?

Ukip’s membership declined from 45,994 at the 2015 general election to 39,000 in 2016. That’s a worrying sign for any political party, which relies on grassroots memberships to put in the campaigning legwork.

What does Ukip's decline mean for Labour and the Conservatives? 

The rise of Ukip took votes from both the Conservatives and Labour, with a nationalist message that appealed to disaffected voters from both right and left. But the decline of Ukip only seems to be helping the Conservatives. Stephen Bush has written about how in Wales voting Ukip seems to have been a gateway drug for traditional Labour voters who are now backing the mainstream right; so the voters Ukip took from the Conservatives are reverting to the Conservatives, and the ones they took from Labour are transferring to the Conservatives too.

Ukip might be finished as an electoral force, but its influence on the rest of British politics will be felt for many years yet. 

0800 7318496